A Health System/Community Partnership for Enhanced Outreach to Prevent Suicide Attempts
Launched by MASSACHUSETTS GENERAL HOSPITAL · Apr 27, 2023
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people who have had thoughts of suicide after they leave the emergency department. The goal is to see if an enhanced outreach intervention (EOI) from a community organization called Samaritans of Boston can reduce behaviors related to suicide, help people keep attending their mental health treatments, and find out if this outreach is acceptable and can be done effectively. Participants will be divided into two groups: one group will receive the usual care from the hospital along with weekly check-ins from Samaritans for 12 weeks, while the other group will only receive the usual hospital care.
To participate, you need to be currently treated for suicidal thoughts in the emergency department and have a smartphone for communication. You should also be comfortable reading in English and willing to share some personal information with the research team and Samaritans. If you join, you can expect regular phone calls or texts to discuss your feelings and coping strategies, as well as messages of support. This study is not yet recruiting, but it aims to provide valuable insights into how we can better support individuals in crisis after an emergency visit.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Currently a patient being treated and evaluated by psychiatry service in an MGB ED
- • 2. Participants enrolled in another study (NCT05671133; PI Nock) conducted by the research team who fall into the top 50% of risk based on the suicide risk prediction algorithm used in that study
- • 3. Able to read English
- • 4. Ownership of a smartphone (iOS or Android) and consistent access to their smartphone following discharge from the current treatment unit or program; ability to be reliably contacted
- • 5. Willing to provide contact information for collateral contact
- • 6. Willing to share contact information and key clinical information with Samaritans of Boston
- • 7. Consent to unencrypted text or email communications
- • 8. Willing to provide social security number (SSN) or individual taxpayer identification number (ITIN) for study compensation
- Exclusion Criteria:
- • 1. Any factor that impairs an individual's ability to comprehend and effectively participate in informed consent, including the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, or acute intoxication
- • 2. Presence of extremely agitated or violent behavior at the time of consent or enrollment
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jordan Smoller, MD, ScD
Principal Investigator
Massachusetts General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported